| scholarly article | Q13442814 |
| P2093 | author name string | Paola Valente | |
| Italo Cantore | |||
| P2860 | cites work | The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis | Q27001157 |
| Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats | Q57091947 | ||
| Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study | Q87412594 | ||
| Discovering drugs to treat coronavirus disease 2019 (COVID-19) | Q87963364 | ||
| Convalescent plasma as a potential therapy for COVID-19 | Q89954633 | ||
| Could Intravenous Immunoglobulin Collected from Recovered Coronavirus Patients Protect against COVID-19 and Strengthen the Immune System of New Patients? | Q90694810 | ||
| Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how | Q91510657 | ||
| Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy | Q91588064 | ||
| Effectiveness of convalescent plasma therapy in severe COVID-19 patients | Q91611037 | ||
| Deployment of convalescent plasma for the prevention and treatment of COVID-19 | Q91618326 | ||
| Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicenter) and outside Hubei (non-epicenter): A Nationwide Analysis of China | Q91737840 | ||
| Reflection on passive immunotherapy in those who need most: some novel strategic arguments for obtaining safer therapeutic plasma or autologous antibodies from recovered COVID -19 infected patients | Q95644632 | ||
| P921 | main subject | COVID-19 | Q84263196 |
| intensive care unit | Q5094647 | ||
| convalescent plasma | Q105209484 | ||
| P304 | page(s) | 102848 | |
| P577 | publication date | 2020-06-10 | |
| P1433 | published in | Transfusion and Apheresis Science | Q15758507 |
| P1476 | title | Convalescent plasma from COVID 19 patients enhances intensive care unit survival rate. A preliminary report |
Search more.